ProQR Therapeutics NV
F:0PQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ProQR Therapeutics NV
F:0PQ
|
NL |
|
Swisscom AG
F:SWJ
|
CH |
|
C
|
Clean Energy Fuels Corp
XMUN:WIQ
|
US |
|
N
|
Nippon Yusen KK
OTC:NYUKF
|
JP |
|
T
|
Teck Resources Ltd
SWB:TPT
|
CA |
|
Impala Platinum Holdings Ltd
OTC:IMPUY
|
ZA |
|
Mitsubishi Electric Corp
LSE:MEL
|
JP |
|
Bengal Energy Ltd
OTC:BNGLF
|
CA |
|
Anglo American Platinum Ltd
OTC:ANGPY
|
ZA |
|
D
|
Daiichi Sankyo Co Ltd
SWB:D4S
|
JP |
|
Siv Capital Ltd
ASX:SIV
|
AU |
|
A
|
Ananda Development PCL
SET:ANAN
|
TH |
|
Addus Homecare Corp
NASDAQ:ADUS
|
US |
|
B
|
BEC World PCL
SET:BEC
|
TH |
|
H
|
Hirata Corp
SWB:1ZM
|
JP |
|
E
|
Engie SA
XMUN:GZF
|
FR |
|
Arabian Centres Company SJSC
SAU:4321
|
SA |
|
J
|
J B Hunt Transport Services Inc
XMUN:JB1
|
US |
|
Hamborner REIT AG
OTC:HMBRF
|
DE |
|
Stella-Jones Inc
F:97S
|
CA |
|
P
|
Peel Mining Ltd
XBER:W5E
|
AU |
|
Tomra Systems ASA
F:TMRA
|
NO |
|
M
|
Mondelez International Inc
XHAM:KTF
|
US |
|
A
|
Aperam SA
XHAM:7AA
|
LU |
Bankruptcy Probability
ProQR Therapeutics NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
ProQR Therapeutics NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NL |
|
ProQR Therapeutics NV
NASDAQ:PRQR
|
173.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
358.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
OpGen Inc
NASDAQ:OPGN
|
156.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
ProQR Therapeutics NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, ProQR Therapeutics NV has total debt of 9.5m EUR. This includes both short-term (0 EUR) and long-term (9.5m EUR) debt.
You can find a full breakdown on its Balance Sheet.
